体外膜肺氧合在妊娠期间的应用。

Extracorporeal Membrane Oxygenation During Pregnancy.

机构信息

Divisions of Maternal Fetal Medicine and Surgical Critical Care,Departments of Obstetrics, Gynecology, and Anesthesiology, University of Texas Medical Branch, Galveston.

Maternal Fetal Medicine/Surgical Critical Care, Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology.

出版信息

Clin Obstet Gynecol. 2023 Mar 1;66(1):151-162. doi: 10.1097/GRF.0000000000000735. Epub 2022 Jul 13.

DOI:10.1097/GRF.0000000000000735

PMID:36044634

Abstract

In the last 2 decades, the use of venovenous (VV) and venoarterial (VA) extracorporeal membrane oxygenation (ECMO) during pregnancy and the postpartum period has increased, mirroring the increased utilization in nonpregnant individuals worldwide. VV ECMO provides respiratory support for patients with acute respiratory distress syndrome (ARDS) who fail conventional mechanical ventilation. With the COVID-19 pandemic, the use of VV ECMO has increased dramatically and data during pregnancy and the postpartum period are overall reassuring. In contrast, VA ECMO provides both respiratory and cardiovascular support. Data on the use of VA ECMO during pregnancy are extremely limited.

摘要

在过去的 20 年中，静脉-静脉（VV）和静脉-动脉（VA）体外膜肺氧合（ECMO）在妊娠和产后期间的使用增加，这与全球范围内非妊娠个体中 ECMO 的使用增加相吻合。VV ECMO 为患有急性呼吸窘迫综合征（ARDS）且常规机械通气失败的患者提供呼吸支持。随着 COVID-19 大流行，VV ECMO 的使用急剧增加，并且妊娠和产后期间的数据总体上令人安心。相比之下，VA ECMO 同时提供呼吸和心血管支持。关于妊娠期间使用 VA ECMO 的数据极为有限。